Yahoo Finance

Interferon Market by Indication, Interferon Type, Administration Route, End User, Product Type, Dosage Form and Region - Shares and Industry Forecast 2025-2030

Dublin, Sept. 08, 2025 (GLOBE NEWSWIRE) -- The "Interferon Market Forecast 2025-2030" has been added to ResearchAndMarkets.com's offering. The interferon market is entering a period of meaningful ...
FierceBiotech

Biogen Idec Receives Approval in the European Union for AVONEX® PEN™

European Commission approves the first single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX (interferon beta-1a) administration “At Biogen Idec, our commitment ...
FierceBiotech

FDA Approves AVONEX® PEN™ and Dose Titration Regimen

Dosing Enhancements May Improve Treatment Experience for Patients Receiving AVONEX® (interferon beta-1a) for Multiple Sclerosis WESTON, Mass.--(BUSINESS WIRE)--Today Biogen Idec (NASDAQ: BIIB) ...
FiercePharma

Biogen Idec Receives Positive Opinion from the CHMP and Authorisation from Health Canada on AVONEX PEN

-- First single-use intramuscular autoinjector designed to improve convenience of once-weekly AVONEX recommended for approval in the European Union and authorised in Canada -- AVONEX PEN is designed ...
Business Wire

CORRECTING and REPLACING Biogen Idec Receives Approval in the European Union for AVONEX ® PEN

ZUG, Switzerland--(BUSINESS WIRE)--Third paragraph, first sentence should read: ....AVONEX 30mcg/0.5ml... (sted ...AVONEX 30mcg/50ml...) The corrected release reads ...
Drug Store News

FDA approves Biogen Idec's Avonex Pen, dose titration regimen

WESTON, Mass. — The Food and Drug Administration has approved two separate dosing innovations for multiple sclerosis patients that are being treated with a Biogen Idec drug. Biogen Idec said the FDA ...